Search Results

1 - 4 of 4 items :

  • Pentoxifylline x
  • Pharmacy, other x
Clear All
Kinetic Modelling of Drug Release from Pentoxifylline Matrix Tablets based on Hydrophilic, Lipophilic and Inert Polymers

criterion for dissolution profile interpretation. Drug Dev Ind Pharm. 2001;27:885-892. [9] Ward A, Clissold SP. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987;34:50-97.

Open access
Synthesis and brain antihypoxic activity of some aliphatic and arylaliphatic amides of caffeine-8-thioglycolic acid

phenols, J. Am. Chem. Soc. 88 (1966) 1020--1024; DOI: 10.1021/ja00957a028. D. L. Bowton, D. A. Stump, D. S. Prough, D. S. Lefkowitz and L. Coker, Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease, Stroke 20 (1989) 1662--1666. C. D. Nicholson, Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia, Psychopharmacology 101 (1990) 147--159; DOI: 10.1007/BF02244119. B. L. Eun, X. H. Liu and J. D. E. Barks

Open access
Core-in-cup/liquisol dual tackling effect on azelnidipine buccoadhesive tablet micromeritics, in vitro release, and mucoadhesive strength

vitro characterization of a new nasal dosage form, Eur. J. Pharm. Sci . 27 (2006) 62–71; https://doi.org/10.1016/j.ejps.2005.08.005 23. M. S. Surapaneni, S. K. Das and N. G. Das, Effect of excipient and processing variables on adhesive properties and release profile of pentoxifylline from mucoadhesive tablets, Drug Dev. Ind. Pharm. 32 (2006) 377–387; https://doi.org/10.1080/03639040500519367 24. A. Tiraferri, P. Maroni, D. Caro Rodriguez and M. Borkovec, Mechanism of chitosan adsorption on silica from aqueous solutions, Langmuir 30 (2014

Open access
The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease

clinical study between the effect of fenofibrate alone and its combination with pentoxifylline on biochemical parameters and liver stiffness in patients with non-alcoholic fatty liver disease, Hepatol. Int. 9 (2015) 471-479; DOI: 10.1007/s12072-015-9633-1. 43. T. Kopf, H. L. Schaefer, M. Troetzmueller, H. Koefeler, M. Broenstrup, T. Konovalova and G. Schmitz, Influence of fenofibrate treatment on triacylglycerides, diacylglycerides and fatty acids in fructose fed rats, PLOS ONE 9 (2014) e106849; DOI: 10.1371/journal.pone.0106849

Open access